financetom
Business
financetom
/
Business
/
Second-Quarter Domestic Box Office Collections Miss Views Amid Thin Film Slate, B. Riley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Second-Quarter Domestic Box Office Collections Miss Views Amid Thin Film Slate, B. Riley Says
Jul 8, 2024 10:02 AM

12:40 PM EDT, 07/08/2024 (MT Newswires) -- Second-quarter domestic box office revenues came in lower than expected because of a relatively thin film slate tied to production delays from last year's Hollywood strikes, B. Riley Securities said in a note emailed Monday.

Box office collections totaled $1.95 billion for the just ended quarter, representing an annual decline of roughly 27%, and below B. Riley's $2.35 billion estimate. The brokerage attributes the weaker-than-expected results to a sparse film schedule caused by production delays from the actors and writers' strikes, rather than changes in movie-going behavior or studios locking out theaters from key releases.

The second-quarter box office had "more than its share of disappointments," such as "Furiosa: A Mad Max Saga," "IF," and "The Fall Guy," B. Riley analyst Eric Wold said in a note.

Trends, however, are expected to improve in the second half as the impact of production delays eases and highly-anticipated films reach theaters, Wold said. "While the production delays adversely impacted the recent recovery path for the domestic box office, we remain positive on the underlying demand trends from individual films across a variety of genres and project a renewed path upward in 2025 and beyond."

People are turning to premium auditoriums, suggesting a desire to escape streaming platforms, Wold wrote.

B. Riley lowered its domestic box office outlook for 2024 to $8.2 billion from $8.5 billion, reflecting the weak second-quarter performance, along with a "slightly more optimistic view" around the subsequent two quarters. For 2025, the brokerage now estimates $9.7 billion in box office proceeds versus its prior projection of $9.9 billion, but it remains "extremely positive" about a rebound.

B. Riley reiterated its buy ratings on Imax ( IMAX ) , Marcus (MCS) and National CineMedia ( NCMI ) stocks. It reaffirmed AMC Entertainment's ( AMC ) neutral rating and upgraded Cinemark (CNK) to buy from neutral.

Price: 17.13, Change: +0.43, Percent Change: +2.54

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Guess? Shares Soar After Fiscal Q4 Outperformance, Special Dividend Payout
Update: Guess? Shares Soar After Fiscal Q4 Outperformance, Special Dividend Payout
Mar 21, 2024
12:40 PM EDT, 03/21/2024 (MT Newswires) -- (Updates with Thursday's stock price movement in the headline and first paragraph.) Guess? (GES) shares were up more than 22% in recent Thursday trading following its better-than-expected Q4 performance and a special dividend payout. Late Wednesday, the company reported fiscal Q4 adjusted earnings of $2.01 per diluted share, up from $1.74 a year...
UN adopts first global artificial intelligence resolution
UN adopts first global artificial intelligence resolution
Mar 21, 2024
(Reuters) - The United Nations General Assembly on Thursday adopted the first global resolution on artificial intelligence to encourage protecting personal data, monitoring AI for risks, and safeguarding human rights, U.S. officials said. The nonbinding resolution, proposed by the United States and co-sponsored by 122 other nations, took three months to negotiate and also advocates strengthening privacy policies, the officials...
Novo Nordisk Says EMA Committee Recommends Marketing Authorization for Diabetes Drug Awiqli
Novo Nordisk Says EMA Committee Recommends Marketing Authorization for Diabetes Drug Awiqli
Mar 21, 2024
12:36 PM EDT, 03/21/2024 (MT Newswires) -- Novo Nordisk ( NVO ) said Thursday the European Medicines Agency's Committee for Medicinal Products for Human Use recommended marketing authorization for Awiqli to treat diabetes in adults. The committee's positive opinion was backed by findings from the phase 3a clinical trial program, which showed that Awiqli, or once-weekly basal insulin icodec, proved...
Update: Darden Shares Fall After Fiscal Q3 Results; 2024 Outlook Updated, $1 Billion Buyback Plan Approved
Update: Darden Shares Fall After Fiscal Q3 Results; 2024 Outlook Updated, $1 Billion Buyback Plan Approved
Mar 21, 2024
12:41 PM EDT, 03/21/2024 (MT Newswires) -- (Updates with Thursday's stock price movement in the headline and first paragraph.) Darden Restaurants ( DRI ) shares were 6% lower in recent Thursday trading after the company reported fiscal Q3 adjusted net earnings from continuing operations of $2.62 per diluted share, up from $2.34 a year earlier. Analysts polled by Capital IQ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved